| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2013/07/19 | 04:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 04:30 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 04:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 04:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 04:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 04:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 04:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 03:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 03:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 03:56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 03:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 03:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 03:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 03:50 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 02:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 02:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 02:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 02:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 02:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 02:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 02:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/19 | 00:39 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/17 | 02:43 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/17 | 01:00 | PR Newswire (US) | Omthera Stockholders Approve Acquisition by AstraZeneca | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/11 | 22:13 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/11 | 06:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/09 | 22:59 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/09 | 22:59 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/07/09 | 19:00 | PR Newswire (US) | Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 2013/06/28 | 00:54 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |